Hereditary Genetic Testing Market Size Projected To Reach $36.22 Billion By 2034 With A Cagr Of 10.9%

The Hereditary Genetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Hereditary Genetic Testing Market?
In recent times, the market size for hereditary genetic testing has experienced rapid expansion. It is projected to escalate from $21.47 billion in 2024 to $23.88 billion in 2025, with a compound annual growth rate (CAGR) of 11.3%. The swell during the historic period can be traced back to the increased occurrence of hereditary diseases, expansion in healthcare informatics, the rise of telemedicine, growth in awareness initiatives, and an increase in the number of available genetic testing platforms.

In the forthcoming years, rapid expansion is projected for the hereditary genetic testing market, with an anticipated valuation of $36.23 billion in 2029, representing an 11.0% compound annual growth rate (CAGR). Factors that could contribute to this growth during the forecast period include an escalated incidence of cancer, increased occurrence of genetic disorders, a surge in demand for diagnostics, more widespread adoption of personalized medicine, and a rise in the number of clinical trials. Technological advancements, whole-genome sequencing, the integration of genetic data, customized medicine, and non-invasive prenatal testing are among the leading trends expected during the forecast period.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20559

What Are the Different Hereditary Genetic Testing Market Segments?
The hereditary genetic testing market covered in this report is segmented -

1) By Type: Predictive And Presymptomatic Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Types
2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing
3) By Clinical Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Rare Diseases Genetic Testing
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Direct To Consumer (DTC) Genetic Testing Companies

Subsegments:
1) By Predictive and Presymptomatic Testing: Genetic Testing For Disease Risk Prediction, Testing For Inherited Cancer Risks, Cardiovascular Disease Risk Testing, Neurodegenerative Disease Risk Testing
2) By Carrier Testing: Testing For Inherited Genetic Disorders, Genetic Screening For Autosomal Recessive Diseases, Testing For Carrier Status Of Inherited Conditions
3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis and Chorionic Villus Sampling (CVS), Newborn Screening For Genetic Disorders, Preconception Genetic Screening
4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders, Testing For Inherited Syndromes and Congenital Diseases, Diagnostic Testing For Cancer and Tumor Profiling
5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy, Testing For Drug Sensitivities and Side Effects, Personalized Medicine and Treatment Optimization
6) By Other Types: Genetic Testing For Wellness And Lifestyle, Genetic Testing For Ancestry And Genealogy, Research-Oriented Genetic Testing

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20559&type=smp

What Are the Primary Drivers Shaping the Hereditary Genetic Testing Market?
The growth of the hereditary genetic testing market is expected to be stimulated by the rising occurrences of cancer. Cancer is a term used to describe a group of illnesses characterized by abnormal cellular growth with the potential to invade or migrate to other body regions. The upsurge in cancer prevalence can be associated with several elements such as changes in lifestyle, environmental pollutants, genetic predispositions, aging populations, and advancements in diagnostic approaches. Hereditary genetic testing plays a key role in cancer prevention, as it detects genetic mutations linked with heightened risks, thus enabling early monitoring and targeted preventative measures. For example, data from the Australian Institute of Health and Welfare, a government agency based in Australia, revealed that there was an increase in the number of diagnosed cancer cases in Australia, going from 156,781 in 2021 to 160,570 in 2022, which represents a year-over-year growth. Therefore, the escalation in cancer occurrences is fuelling the expansion of the hereditary genetic testing market.

Which Companies Are Leading in the Hereditary Genetic Testing Market?
Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Amgen Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, NeoGenomics Laboratories Inc., 23andMe Inc., MyHeritage Ltd., Color Health Inc., MedGenome Inc., SOPHiA GENETICS SA, Devyser AB, Mapmygenome India Ltd., Igenomix S.L.

What Are the Major Trends Shaping the Alcohol Based Disinfectants Market?
To enhance early detection and personalised treatment strategies, major players in the hereditary genetic testing market are concentrating on the development of sophisticated genomic solutions like multi-cancer multigene panels. These panels are diagnostic tests which examine numerous genes at once to identify genetic alterations associated with different types of cancer, thereby enabling early detection and individualised treatment. For example, Exact Sciences Corporation, a U.S. firm specialising in cancer screening and diagnostic tests, introduced the Riskguard hereditary cancer test in February 2024. The Riskguard test provides a gene-specific and familial cancer risk personalised report using a basic blood or saliva sample for ten prevalent types of cancer. This facilitates understanding cancer risk, planning screening and treatment, and evaluating familial risks. Furthermore, it customises treatment for cancer patients and improves risk classification for those with a family history of cancer by discovering actionable gene variants.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/hereditary-genetic-testing-global-market-report

What Are the Top Revenue-Generating Geographies in the Hereditary Genetic Testing Market?
North America was the largest region in the hereditary genetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Hereditary Genetic Testing Market?
2. What is the CAGR expected in the Hereditary Genetic Testing Market?
3. What Are the Key Innovations Transforming the Hereditary Genetic Testing Industry?
4. Which Region Is Leading the Hereditary Genetic Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the hereditary genetic testing market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.